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Abstract 
 
The eukaryotic Chaperonin Containing TCP-1 (CCT) is a heterooligomeric 
chaperonin essential for enabling the cytoskeletal proteins actin and tubulin to 
fold to their native state.  The eight CCT subunits are encoded by individual 
genes and are present in cells as the ~960kDa oligomer, as components of 
micro-complexes, and as monomeric subunits.  In addition to the well-
characterised substrate folding mechanism of the CCT oligomer, roles for CCT 
subunits as monomeric proteins are emerging.  The work in this thesis illustrates 
the dependence upon functional CCT and its roles in cytoskeletal organisation.  
Levels of functional CCT have far-reaching implications for cellular functions 
dependent upon an intact cytoskeleton and siRNA targeting of CCT subunits 
results in growth arrest and reduced levels of native actin and tubulin.  Targeting 
each CCT subunit individually by siRNA revealed different effects upon 
cytoskeletal organisation, suggestive of distinct roles for specific CCT 
monomers.  Cell shape and microfilament polymerisation are influenced by 
CCT monomers with CCTε levels appearing particularly important for these 
processes.  Furthermore, CCTε and to a lesser extent ζ and θ were found to co-
localise to microfilaments and CCT subunits associated with non-soluble protein 
assemblies following detergent extraction are predominantly monomeric.  
Gelsolin, an actin filament severing and capping protein was identified as a 
CCT-binding protein, providing another link between CCT activity and 
cytoskeletal organisation.  Although shown to bind the CCT oligomer with some 
degree of specificity, it is most likely that gelsolin does not represent a CCT 
folding substrate.  siRNA of CCT subunits influences gelsolin levels differently 
depending upon the target subunit, suggestive of some regulation between CCT 
monomers, F-actin, and gelsolin levels.   
The work presented in this thesis indicates that CCT influences the mammalian 
cytoskeleton far beyond its involvement in folding newly synthesised actin and 
tubulin polypeptides and implicates CCT subunits in their monomeric assembly 
state as likely perpetrators of such activity. 
 
Keywords: CCT, TRiC, Chaperonin, Molecular chaperone, Cytoskeleton, Actin, Tubulin, 
Gelsolin 
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The cytoskeleton is composed of filamentous protein polymers called 
microfilaments, microtubules and intermediate filaments.  These networks along 
with families of accessory proteins enable many important cellular processes.   
The cytoskeleton is often regarded as scaffolding running throughout the cell.  
This is suggestive of a rigid supportive structure and although filaments of these 
networks are strong enough to withstand forces both from outside and within 
cells, this is a huge injustice to the complex and dynamic nature of the 
cytoskeleton.   
Without an intact functional cytoskeleton, we would be unable to contract our 
muscles (important not only for movement, but also for a heartbeat), our neurons 
would be unable to branch out and make new connections, cells would be unable 
to move and unable to divide.  Obviously, based upon these very few examples 
alone, we have a lot to thank these proteins for.   
Therefore, it is crucial that cells are able to maintain their supplies of the 
proteins which form these cytoskeletal structures, and also, and maybe more 
importantly that these building blocks have the correct structure to allow them to 
be incorporated correctly into these filaments.  For actin (the protein 
microfilaments are made from) and tubulin (the building blocks of 
microtubules), this is the responsibility of the molecular chaperone Chaperonin 
Containing TCP-1 (CCT).  CCT actively assists during the folding of these 
proteins allowing them to achieve their correct 3-dimensional structure, a 
process vital for a functional cytoskeleton and all downstream processes 
dependent upon it.     
The work in this thesis looks more closely at the relationship between the 
cytoskeleton and this molecular chaperone, establishing that interactions extend 
beyond those enabling folding of newly synthesised proteins to include 
interactions between CCT subunits and native proteins in established 
cytoskeletal networks.   
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Mammalian actin and tubulin cytoskeletal networks 
 
Within mammalian cells there are three cytoskeletal networks, microfilaments 
(composed of actin monomers) microtubules (built from tubulin heterodimers) 
and intermediate filaments (assembled from different intermediate filament 
proteins), together these constitute the mammalian cytoskeleton. These 
cytoskeletal structures are important for a whole host of cellular functions and 
many of their properties are dependent upon their dynamic nature and a host of 
accessory proteins.  The assembly and dynamics of microtubules and, more 
relevantly for the work presented in this thesis, microfilaments, will be briefly 
discussed here.     
Microtubules are hollow tubes composed of tubulin α/β-heterodimers.  Tubulin 
binding co-factors enable α/β-tubulin heterodimer formation from α- and β- 
tubulin monomers.  Heterodimers then align to form protofilaments, which 
subsequently associate laterally forming cylindrical microtubules.  Microtubules 
are polarised relative to their nucleation from the microtubule organising centre 
(MTOC) and most dynamic at their plus end, located towards the cell periphery.  
Rapid assembly and disassembly of microtubules is pivotal to their functions.  
Microtubules experience “dynamic instability” whereby they can rapidly 
fluctuate between elongation and shrinkage.  Microtubules are often considered 
as transportation networks throughout the cell as the motor proteins kinesins and 
dyneins travel along microtubules transporting cargo proteins and vesicles to 
intracellular locations.  In addition to motor proteins, a whole host of other 
proteins, collectively referred to as Microtubule Associated Proteins (MAPs) 
bind to microtubules, regulating their activity and assembly (reviewed by e.g. 
Desai and Mitchison, 1997; Valiron et al., 2001). 
Microfilaments are composed of actin monomers, the requirements of actin and 
tubulin differ prior to filament incorporation in that no equivalents of tubulin co-
factors are necessary in the actin system.  Like microtubules, microfilament 
formation begins with a nucleation step dependent upon actin monomer 
concentrations.  The plus and minus ends of actin filaments are also referred to 
as the barbed and pointed ends respectively; following nucleation, monomers 
associate most rapidly with the barbed end of filaments.  Again, as for 
microtubules, it is essential that microfilaments are dynamic, thereby enabling 
cell motility and morphological changes.  Actin filaments are regulated by a host 
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of proteins termed actin binding proteins.  Actin binding proteins can be sub-
divided into a few key categories, including: i) Actin monomer-binding proteins, 
these control the pool of unpolymerised actin within cells, e.g. β-thymosins and 
profilin.  ii) Actin filament-capping proteins, that can bind barded or pointed 
ends of actin filaments and prevent subunit association/disassociation.  iii) Actin 
filament-severing proteins create short fragmented filaments and iv) Actin 
filament cross-linking proteins, which enable microfilaments to assemble into 
higher order structures such as stress fibres.  Stress fibres contain many actin 
filaments bundled together with alternating polarities and myosin II filaments 
that give stress fibres their contractile properties.  As with individual actin 
filaments, stress fibres are also regulated by an array of actin binding proteins.  
Stress fibre assemblies can be classified into three main types with differing 
assembly mechanisms and intracellular locations; traverse arcs lay parallel to the 
lamellipodia structures at cell edges, dorsal stress fibres elongate from the cell 
edge towards the dorsal surface, and ventral stress fibres, which are anchored by 
focal adhesions at both ends (reviewed by e.g. dos Remedios et al., 2003; 
Hotulainen and Lappalainen, 2006; Naumanen et al., 2008; Pellegrin and 
Mellor, 2007; Pollard, 1990).  
The structural and dynamic nature of the cytoskeleton is paramount to cell 
function.  During protein folding it is the molecular chaperone CCT which 
ensures that actin and tubulin attain their native conformations ready for 
incorporation into cytoskeletal networks.  Incorporation of misfolded proteins 
into filaments would have potentally detrimental affects upon cytoskeletal 
functions, therefore demonstrating the importance of CCT.    
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Chaperonin Containing TCP-1 
 
Chaperonin Containing TCP-1 (CCT, also known as TCP-1 Ring Complex or 
TRiC) is a eukaryotic chaperonin essential for the folding of newly synthesised 
actin and tubulin monomers.  Chaperonins are a specialised sub-group of a class 
of proteins, known as molecular chaperones, which assist in the folding of newly 
synthesised proteins.  Before describing the chaperonins in more detail, some 
basic principals need to be considered, namely, why do proteins require 
assistance to fold and how do molecular chaperones achieve this?  
 
Protein folding in the crowded cell environment 
In order to be functional, proteins must have adopted their correct three-
dimensional structure.  There are different occasions when proteins will be 
unfolded and therefore require assistance from the cellular protein folding 
machinery in order to prevent their aggregation.  If proteins are localised to 
particular cellular compartments, during translocation they may adopt linear 
formations to enable passage through membranes and therefore need refolding 
upon reaching their destination.  Additionally, proteins can experience off-
pathway folding reactions during conditions of cellular stress and require 
assistance to try to regain native structure and prevent aggregation.  However, 
the bulk of cellular protein folding activity occurs when proteins are newly 
translated as polypeptide chains and need to fold to their correct conformation.   
As newly synthesised polypeptides emerge from the ribosome into the cell they 
are confronted with the daunting task of reaching their native conformation 
whilst in a crowded environment, i.e. surrounded by high macromolecule 
concentrations (200-400mg/ml protein and RNA (Ellis, 1997)).  Proteins of 
approximately 300 amino acid residues can take up to 1 minute to be translated 
and since the newly synthesised polypeptide becomes available in a vectoral 
manner during translation, this means that regions which are translated first may 
be susceptible to aggregation before the rest of the protein has been translated 
(Hartl and Hayer-Hartl, 2002).  The exit site of the ribosome itself is too narrow 
to allow formation of protein structure (Nissen et al., 2000) and therefore newly 
synthesised polypeptide chains must emerge during translation, vulnerable to the 
crowded, protein-rich conditions of the cell environment.  This increases the 
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possibility that proteins may fail to reach their native conformations, either by 
failing to fold correctly upon exit from the ribosome or by later “off-pathway” 
events resulting in loss of native structure.  Either way, non-native protein 
conformations can result in protein aggregation, a potentially dangerous threat to 
the cells’ survival.  Protein aggregation is often associated with disease; 
particularly neurological disorders such as Alzheimer’s and Parkinson’s diseases 
that arise when proteins misfold and resulting aggregates are deposited in cells 
or tissues (e.g. Dobson, 2003; Stefani and Dobson, 2003).  Although individual 
diseases are usually associated with misfolding of one particular protein, 
Bucciantini et al., have shown that proteins other than those classically 
associated with amyloid diseases are capable of aggregate formation, producing 
levels of cytotoxicity comparable to those of Aβ (1-42) (common in Alzheimer’s 
disease) (Bucciantini et al., 2002).   
Anfinsen (e.g. 1973) proposed a model whereby the amino acid sequence of a 
nascent polypeptide will dictate the protein’s native state, and whilst this 
remains true, we now know that as well as the polypeptide sequences’ intrinsic 
properties, the cell contains proteins intent on ensuring other proteins can fold to 
their correct conformation.  Molecular chaperones are a group of proteins, often 
working together, assisting nascent polypeptide chains to reach their native 
conformation, smoothing folding energy landscapes and offering protection 
from the crowded cytoplasm, allowing safe release of newly synthesised 
proteins (e.g. Ellis, 1997).  Most molecular chaperones require ATP hydrolysis 
for their mechanism of action.  Although this investment of ATP in the folding 
of newly synthesised polypeptides and those that have gone off-pathway may 
seem expensive to the cell, the alternative may be protein aggregation, with 
potentially catastrophic consequences.  Furthermore, the cost of re-folding a 
protein that has gone off-pathway is only ~10% of the energy required for initial 
translation (Horwich et al., 2007).  Therefore, cells may save energy “repairing” 
misfolded proteins using molecular chaperones as opposed to re-synthesising 
new ones to replace them. 
 
Mammalian molecular chaperone systems 
More than 20 years ago the term ‘molecular chaperones’ was designated to 
describe “a class of cellular proteins whose function is to ensure that the folding 
of certain other polypeptide chains and their assembly into oligomeric structures 
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occur correctly” (Ellis, 1987).  Chaperones are therefore often responsible for 
the final step in producing biologically active proteins following transcription 
and translation.  Many molecular chaperones are designated (and were first 
identified) as heat shock proteins (Hsps) based upon their up-regulation during 
cellular stress.  However, they are also necessary for many of the 
‘housekeeping’ processes in cells growing under normal conditions.  
Mammalian chaperones include the Hsp70, Hsp90 and chaperonin systems.  
Some chaperones may cooperate with each other and many newly synthesised 
proteins will interact with more than one type of chaperone and their host of 
accessory proteins / co-chaperones before reaching their native conformation.  
Figure 1 demonstrates the different pathways newly synthesised proteins may 
take and the chaperones they can interact with between exiting the ribosome and 
reaching their correct conformation in the cell cytosol.  The sooner proteins can 
interact with chaperones the less likely they are to go off pathway.  The first line 
of defence against protein aggregation are chaperones which are ribosome 
bound, interacting with nascent polypeptide chains co-translationally (Craig et 
al., 2003).  The eukaryotic NAC (nascent chain-associated complex) binds and 
protects stretches of hydrophobic residues in emerging nascent chains.  This 
activity is ATP independent and is not known to actively prevent aggregation, 
instead it appears as more of a stabilising, protective measure whilst peptide 
chains wait for completion of their translation and release from the ribosome, 
following which NAC complex dissociates from polypeptide chains (reviewed 
by e.g. Hartl and Hayer-Hartl, 2002; Young et al., 2004).  The constitutively 
expressed Hsp70 homologue Hsc70 can also interact with nascent chains and 
has a very general clientele as it recognises exposed hydrophobic sequences, 
common to most nascent polypeptide chains.  Interactions with Hsp70 vary 
depending upon a protein’s size.  The larger a protein is, the more likely an 
interaction is needed for efficient protein folding.  Up to 20% of bacterial 
proteins interact with the Hsp70 homologue DnaK whereas eukaryotic proteins 
are generally larger, and therefore a higher percentage will utilise the Hsp70 
chaperone family during their folding pathways (Mayer and Bukau, 2005).  
Unlike the ribosome-tethered NAC complex, the activity of Hsp70 chaperones is 
ATP dependent and their ATP hydrolysis cycle controls the rate of protein 
folding.  The rate-limiting ATP hydrolysis step of Hsp70 protein folding can be 
stimulated by Hsp40, a co-chaperone that mediates interactions with newly 
synthesised proteins, subsequently transferring them to Hsp70 (Wegele et al 
2006).   
15 
   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1:  Mammalian pathways of chaperone assisted protein folding.  Whilst some simple 
proteins may be able to reach their native conformation without assistance from molecular 
chaperones, many cannot.  The cell contains multiple chaperone pathways.  Proteins may 
utilise cross talk between pathways and a host of co-chaperones and folding cofactors to 
become folded to their correct three-dimensional structure.  Based upon Young et al., (2004).   
 
Cytoplasmic Hsp90 is essential for eukaryotic cell viability and is one of the 
most abundant proteins in cells under non-stressed conditions, accounting for 1-
2% of soluble cell protein (e.g. Lai et al., 1984), however it is not required for 
the de novo protein folding of most proteins (Nathan et al., 1997).  Instead, the 
ATP dependent Hsp90 chaperone machinery appears to regulate the activity of 
proteins, especially those involved in signalling pathways.  Hsp90’s functional 
mechanisms, selectivity for client proteins and their binding mechanisms are 
still not well understood (reviewed by e.g. Pearl and Prodromou, 2006; Wegele 
et al., 2004; Young et al., 2004).  The Hsp organising protein (Hop) links the 
Hsp70 and Hsp90 chaperones in mammalian systems, facilitating substrate 
transfer without influencing the ATPase activity of either (Johnson et al., 1998; 
Wegele et al., 2006).  Hsp90 client proteins can be divided into three main 
groups; protein kinases, transcription factors and structurally unrelated proteins 
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(reviewed by Pearl et al., 2008).  Hsp90 selectively interacts with kinases which 
act as informational hubs in signalling networks (Citri et al., 2006), including 
many involved in oncogenesis such as c-Src, PKB/Akt1 and Cdk4.  Hsp90 plays 
important roles in disease states and especially cancers.  Its function has been 
implicated in many of the hallmark steps of cancer and elevated Hsp90 levels 
are linked to poor prognosis.  Hsp90 inhibitors are being developed for cancer 
treatment  and should have wide reaching impacts due to the large number of 
client proteins involved in oncogenesis (reviewed by Neckers, 2007; Pearl et al., 
2008).  Additionally, Hsp90’s interaction with the mutant form of cystic fibrosis 
transmembrane conductance regulator has been suggested to contribute to the 
disease pathology of cystic fibrosis (Wang et al., 2006) and Hsp90 is also 
involved in viral replication complex assembly.    
 
The chaperonins 
Chaperonins are a sub-class of molecular chaperones.  Chaperonins are sub-
divided into Group I chaperonins (found in eubacteria and endosymbiotic 
organelles), of which the GroEL/GroES system is the most well characterised 
example, and Group II chaperonins (from archeabacteria and the eukaryotic 
cytosol) which include the thermosome and CCT.  The chaperonins all have a 
cylindrical shape composed of two back-to-back rings surrounding a central 
folding cavity.  This cavity offers a protective environment, reducing the effects 
of molecular crowding during a substrate’s folding cycle.  Demonstrating how 
important they are for protein folding, chaperonins are present in all three 
kingdoms of life and moreover are essential proteins, E.coli and S. cerevisiae  
deficient for GroEL or CCT subunits respectively are non-viable (Fayet et al., 
1989; Stoldt et al., 1996).   
Each chaperonin ring contains between seven and nine individual subunits, of 
approximately 60kDa resulting in the total molecular weight of chaperonins 
reaching up to 1MDa.  Features, such as dependence upon a functional ATP 
cycle and the domain architecture of chaperonin subunits are conserved amongst 
all chaperonins.  Within each subunit there are three distinct domains (figure 
2c), the apical domain is responsible for substrate capture whilst the equatorial 
domain contains the highly conserved ATP nucleotide binding site and mediates 
inter- and intra-ring communication.  Communication between the apical and 
equatorial domains within each subunit occurs via the flexible hinge-like 
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(Kubota et al., 1997)).  Liou and Willison deduced that these subunits have a 
fixed position within the rings, as shown in Figure 2b  (Liou and Willison, 
1997).  CCT subunits are most divergent in their apical domain sequences and 
CCT orthologues have areas of related sequence in polypeptide binding regions 
across species (Kim et al., 1994).  GroEL and CCT share sequence similarities 
in both the equatorial and intermediate domains but display no significant 
sequence homology in the polypeptide binding regions of the apical domains.  
Differences between the two chaperonins in this region suggest that substrate-
binding mechanisms may differ.  Substrates binding GroEL have only one type 
of subunit protein to bind, whereas CCT offers eight different proteins with 
diverse sequences.  Therefore, CCT has a much more complex binding interface 
to offer its client proteins compared to its bacterial counterpart.  Furthermore, 
CCT substrate binding sites have been aligned to specific resides underneath the 
apical domain helical protrusions (Pappenberger et al., 2002).  The fact that 
these are polar amino acid residues suggests that the binding of actin and tubulin 
could be sequence-specific and not just via general hydrophobic binding 
mechanisms that would generally detect non-native proteins.  The different 
mechanisms by which GroEL and CCT interact with their client proteins 
indicates much more general substrate-capture mechanisms for GroEL 
compared to the CCT chaperonin system.  Furthermore, GroEL, mitochondrial 
Hsp60 and the thermosome are all heat inducible whereas CCT is not up-
regulated during heat shock (Horwich et al., 2007).  Therefore, whilst other 
chaperonins are able to assist with general protein folding, under stress 
conditions, CCT does not mediate general refolding of heat induced off-pathway 
conformations suggesting that under normal cell conditions CCT satisfies a very 
specific folding requirement within the eukaryotic cytosol.   
From cryoelectron microscopy studies of actin and tubulin bound CCT, it seems 
that CCT substrates remain bound to the chaperonin (Llorca et al., 2001b).  In 
the GroEL/GroES system substrates are released into the cavity for folding.    
Therefore, if substrates remain bound, CCT potentially offers greater levels of 
active assistance in protein folding compared to the GroEL/GroES system, 
which can be considered as a more passive, yet protected, folding environment. 
In agreement with this is the way in which different chaperonins execute their 
ATP hydrolysis cycles.  GroEL subunits hydrolyse their ATP nucleotides in a  
concerted manner (Yifrach and Horovitz, 1995) whilst CCT subunits hydrolyse 
their ATP in a defined order as a wave around the CCT ring (Lin and Sherman, 
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1997; Rivenzon-Segal et al., 2005), a process which allows conformational 
rearrangements of substrates bound across the cavity (Llorca et al., 2001b).  
 
CCT substrates 
CCT was originally identified as a chaperone mediating actin and tubulin 
folding (Gao et al., 1992; Sternlicht et al., 1993; Ursic and Culbertson, 1991; 
Yaffe et al., 1992) and these are still considered the archetypal obligate 
substrates of this chaperonin.  Tubulin-CCT interactions involve all eight of 
CCT’s subunits, suggesting that CCT may have evolved for tubulin folding 
requirements and later adapted during actin evolution to accommodate its 
folding requirements.  Actin has ancestral genes dating back ~three billion years 
(Pollard and Cooper, 2009) and prokaryotic actin predecessors such as MreB 
can fold to their native conformation and even polymerise into functional 
filamentous structures (Carballido-Lopez and Errington, 2003; Michie and 
Lowe, 2006; van den Ent et al., 2001) without CCT.  However, eukaryotic actin 
is unable to reach a native conformation unassisted and GroEL cannot replace 
the need for CCT (Pappenberger et al., 2006; Stemp et al., 2005).  Altschuler 
and Willison (2008) propose that CCT overcomes particular folding difficulties 
faced by eukaryotic actin.  CCT’s adaptation to accommodate actin folding 
function is supported by the fact that during the evolution of individual CCT 
subunits by gene duplications, CCTδ/ε and α/β/η clades are those that evolved 
most recently (Archibald et al., 2000) and CCTβ, δ and ε are those responsible 
for actin-specific substrate interactions.   
Apart from actin and tubulin, until recently only a limited number of proteins 
had been identified as CCT substrates (reviewed by Dunn et al., 2001; Valpuesta 
et al., 2002; Willison and Grantham, 2001) 
A number of cell cycle related proteins have been identified as CCT substrates, 
including Polo-like kinase 1 (Plk1) involved in G2/M cell-cycle progression (Liu 
et al., 2005) and in CCT siRNA targeted cells, Plk1 levels are reduced, 
consistent with this (paper I).  Cyclin E has also been identified as a CCT 
binding protein (Won et al., 1998), (although data in paper I suggest that it does 
not behave as a CCT substrate).  Cdc20 and Cdh1 are cell cycle proteins 
responsible for APC/C activation at mitosis and G1 respectively, these proteins 
rely upon CCT for two aspects of their function (Camasses et al., 2003).   
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Firstly, Cdc20 and Cdh1 rely upon CCT as substrates to achieve their native 
protein structures.  Both of these proteins are WD repeat proteins, a class of 
proteins that have been shown to commonly use CCT for their protein folding 
requirements.  Ho et al., (2002) performed a screen for protein-protein 
interactions using immunoprecipitation and mass-spectrometry and from the 21 
proteins interacting with 3 or more CCT subunit proteins, 16 were WD repeat 
proteins (Ho et al., 2002), representing 17% of the total yeast WD repeat 
proteins (Valpuesta et al., 2002).  This protein fold may require assistance from 
CCT; moreover, these propeller-shaped β-sheet structures would fit within the 
dimensions of the CCT cavity (Craig, 2003; Valpuesta et al., 2002).  Despite 
having 7-blade β-sheet propeller structures, the interaction between CCT and 
Cdc20 / Cdh1 was mapped to blades III through V, suggesting that specific 
recognition mechanisms exist allowing CCT to distinguish not only between 
different WD repeat proteins, but also between their different blades (Camasses 
et al., 2003).  Secondly, following folding to their native structure, Cdc20 and 
Cdh1 then use CCT as a platform for assembly into functional complexes with 
APC/C.  This mechanism may allow a high degree of regulation by “just-in-
time” assembly, in other words if Cdc20-APC/C complex assembly is the rate 
limiting step for cell cycle progression, this is regulated by CCT activity levels 
(Dekker, 2010). 
In a similar manner to Cdc20 and Cdh1, the von Hippel-Lindau (VHL) tumour 
suppressor protein also uses CCT for folding and assembly.  VHL represents a 
genuine folding substrate of CCT but, after folding, utilises CCT as a platform 
for its assembly into a functional complex with elongin B and elongin C 
(Feldman et al., 1999; Melville et al., 2003).   
Recently, two studies in yeast greatly contributed to our current knowledge of 
CCT interacting proteins (Dekker et al., 2008; Yam et al., 2008).  136 CCT 
interacting genes/proteins were identified using both proteomic and genomic 
approaches (Dekker et al., 2008) and via a genome-wide small pool expression 
cloning approach a higher estimation was made that 6-7% of cytosolic proteins 
interact with CCT (Yam et al., 2008).  Proteins that interact with CCT were 
shown to have a propensity toward being components of oligomeric assemblies 
and/or enriched for regions of β-sheet (Yam et al., 2008).  CCT interacting 
proteins identified using these methods will not all represent proteins which 
have an obligate requirement for CCT and cannot reach their native state in 
systems lacking the chaperonin (such as actin and tubulin).  Additional 
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categories of interacting partners include: i) proteins that bind to CCT as 
regulatory proteins, assisting with protein folding, either by delivering substrates 
to the ring or by regulating the folding activity/rate of CCT; ii) proteins using 
CCT as a platform for oligomerisation and iii) proteins which may have 
developed off-pathway conformations and bound to CCT opportunistically to try 
and re-fold.  Proteins belonging to any of these three categories do not represent 
obligate folding substrates of CCT.      
Dekker and colleagues (2008) identified components of the septin ring complex 
as a novel group of CCT-interacting cytoskeletal proteins.  They also identified 
a number of proteins with nuclear functions, including proteins that make up the 
nuclear pore complex and those involved in nuclear transport.  Additionally 
histone deacetylases were identified as CCT binding partners, consistent with a 
previous report that HDAC3 deacetylase requires CCT for its activation, via 
assembly into a complex with SMRT (Guenther et al., 2002).   
It can be seen that CCT interacts with a diverse range of interacting proteins 
which utilise the chaperonin to satisfy different requirements during their 
maturation into functional proteins.  Techniques to detect protein-protein 
interactions are increasing in sensitivity, allowing interactions that occur with 
lower abundance or more transiently to be detected; consequently, the pool of 
known CCT interacting proteins is expanding.  As this number increases, it will 
become easier to establish if any shared characteristics / folding requirements 
exist amongst them as currently very little is known.  It will also be important to 
determine which proteins represent those with an absolute requirement for CCT 
in order to achieve their native structure.   
 
Actin and tubulin – obligate CCT folding substrates 
The main substrates of CCT are the essential cytoskeletal proteins actin and 
tubulin (Gao et al., 1992), both of which depend upon CCT to reach their native 
conformations (Tian et al., 1995b).  Following translation, actin and tubulin 
polypeptides are presented to CCT in a quasi-native state (discussed below) and 
it has been proposed that the ATP independent chaperone prefoldin (GimC in 
yeast), binds to nascent chains and delivers them to chaperonins for further 
folding (e.g. Hansen et al., 1999; Siegers et al., 2003; Vainberg et al., 1998).  
Eukaryotic prefoldin has more complex subunit compositions and substrate 
binding mechanisms (Leroux et al., 1999; Martin-Benito et al., 2007a) than its 
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archeal counterpart and three-dimensional reconstructions have shown 
interactions between prefoldin and specific CCT apical domains, presenting a 
mechanism for delivery of partially folded actin to the chaperonin (Martin-
Benito et al., 2002). 
Both actin and tubulin are able to adopt two different orientations across the 
chaperonin cavity, binding subunits on opposing sides of the ring.  Actin 
interacts with two CCT subunits upon binding with the small (N-terminal) 
domain of actin binding constitutively to CCTδ whilst the larger (C-terminal) 
domain of actin binds to either CCTε or β (Llorca et al., 1999a).  The interaction 
of CCT with tubulin also occurs via two different binding orientations, however, 
in the case of tubulin each binding orientation utilises five CCT subunits.  The 
N-terminal binds CCTθ and δ and the C-terminal binds to CCTε, ζ and β or the 
N-terminal binds CCTη and α and the C-terminal binds CCTβ, γ and θ (Llorca et 
al., 2000),  as shown in Figure 3A.   
CCT subunits involved in actin interactions have been identified, shown in 
Figure 3B (Hynes and Willison, 2000; Llorca et al., 2001a; Llorca et al., 1999a), 
and the actin sequences responsible for CCT binding and folding have been 
mapped (Hynes and Willison, 2000; Neirynck et al., 2006; Rommelaere et al., 
1999).  These sites are interesting because normally chaperone-substrate 
interactions occur via hydrophobic interactions in areas of the protein that will 
be buried inside the native protein structure.  However, in the case of actin, CCT 
interacting sequences have been mapped to the surface of native actin, 
suggesting that actin interacts with the chaperonin as a quasi-native folding-
intermediate with a high-degree of folded structure (Llorca et al., 2000; Tian et 
al., 1995a).  Different sub-domains of the actin molecule bind CCT subunits on 
opposing sides of the chaperonin ring, stretching it across the chaperonin ring 
(Llorca et al., 1999a), separating sub-domains 2 and 4 and expanding the ATP 
binding cleft (Villebeck et al., 2007).  GroEL is unable to fold native actin 
(Stemp et al., 2005)  and this may result from the absence of such expansion 
during β-actin–GroEL interactions (Villebeck et al., 2007).  ATP binding 
promotes the closure of an in-built lid from the apical domains of CCT, thereby 
closing the cavity (Llorca et al., 2001b), which has been shown to be essential 
for productive folding of actin to its native state (Reissmann et al., 2007).  
However, unlike the GroEL system cavity closure does not induce release of 
substrate into the cavity.  ATP hydrolysis induces conformational changes in  
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Figure 3: Possible binding orientations of tubulin (A) and actin (B) to CCT.  Conformational 
rearrangements of actin are determined by the ATP hydrolysis cycle of CCT (C).  The N-
termini of CCT substrates (grey) are more easily released from the ring than the C-termini 
(black) which are bound with higher affinity (Hynes and Willison, 2000; Llorca et al., 2001b).  
Upon ATP hydrolysis, which occurs sequentially around the ring (Lin and Sherman, 1997), 
actin moves across the cavity creating a more compact structure, but one which remains 
attached to the chaperonin (Llorca et al., 2001b). 
 
CCT sequentially around the ring in a defined order (Lin and Sherman, 1997), 
resulting in movement of substrates from being extended across the cavity to a 
more compact structure as shown in figure 3C.  This hinge-like movement of 
actin around its nucleotide cleft is important and mutants in this region prevent 
actin maturing to its native state and result in lack of substrate release from the 
chaperonin (McCormack et al., 2001a; Neirynck et al., 2006).  Nucleotide 
hydrolysis by CCT subunits therefore directly influences actins’ structural 
conformation, demonstrating that the chaperonin plays an active role in protein 
folding as opposed to merely providing an environment to allow passive folding 
to occur (as reviewed by, e.g. Brackley and Grantham, 2009; Gutsche et al., 
1999; Horwich et al., 2007).  Actin is released from CCT as a productive folding 
intermediate which is stabilised by nucleotide and cation binding (Altschuler 
and Willison, 2008).  It is uncertain whether actin needs to bind cyclase 
associated protein (CAP) to become loaded with nucleotide, or whether this final 
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step towards the maturation of actin occurs whilst bound to CCT, but once 
achieved, actin monomers are native and able to be incorporated into 
microfilaments.       
 
CCT regulation by phosducin-like proteins 
Recently a role for the family of phosducin-like proteins as regulators of CCT 
activity has emerged.  Originally linked to G-protein signalling, these proteins 
have been shown to bind to CCT in their native state and regulate CCT-
mediated folding (reviewed by Willardson and Howlett, 2007). Three phosducin 
like proteins have been shown to interact with CCT, but so far their roles are not 
clearly defined.  For example, using an in vitro yeast CCT-actin folding system, 
McCormack et al., (2009) have shown that, via direct interactions between the 
C-terminus of Plp2p and actin subdomain 4, Plp2p stimulates actin folding, 
increasing yields by up to 30 fold (McCormack et al., 2009).  This is 
contradictory to the inhibitory effect of human PDCL3 (PhLP2) on CCT folding 
activity (McCormack et al., 2009; Stirling et al., 2007), suggesting that higher 
eukaryotes may have developed additional regulatory mechanisms governing 
phosducin-like protein mediated CCT-substrate folding (McCormack et al., 
2009).  Our understanding of CCT function in vivo will be greatly enhanced as 
we begin to understand more about the complex regulation of CCT substrate 
folding by co-chaperones and regulatory proteins.   
 
Roles for CCT monomeric subunits: 
CCT’s assistance during the folding of newly synthesised proteins fulfils the 
classic job description of a molecular chaperone.  However, it has been shown 
that CCT has other functional roles, and the focus of the work presented in this 
thesis extends our knowledge of such non-classical CCT interactions.  Although 
the majority of cellular CCT is in the oligomeric assembly state, the cell also 
contains CCT subunits as monomeric entities or within micro-complexes 
composed of a few CCT subunits (Liou and Willison, 1997), additionally, the 
CCT oligomer is dynamic and can assemble and disassemble under 
physiological conditions (Roobol et al., 1999a).  Interestingly, some CCT 
interactions occur independently of the chaperonin oligomer and roles for 
monomeric CCT subunits are emerging.  For example, CCT α, γ, ζ and θ have 
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been identified as microtubule associated proteins (Roobol et al., 1999b) and 
CCTα (independently or possibly within the oligomer) has been shown to 
localise to the centrosome (Brown et al., 1996) and to microtubule derived 
structures important for spermiogenesis (Soues et al., 2003).  CCT subunits have 
recently been implicated in the suppression of polyglutamine aggregates 
(Behrends et al., 2006; Kitamura et al., 2006; Tam et al., 2006; Tam et al., 
2009).  Tam et al., (2006) found that in yeast, aggregation can be suppressed by 
over-expression of CCT1 or CCT4 and interestingly, the apical domain of CCT1 
alone is sufficient to suppress aggregation, whilst other subunits do not mediate 
similar effects (Tam et al., 2006).  This once again demonstrates the specific 
binding characteristics of individual CCT subunits and effectively rules out a 
requirement for the oligomer in polyglutamine aggregation suppression.  
Similarly, overexpression of CCT6 can, in an ATP binding dependant manner, 
rescue abnormal cell phenotypes in S. cerevisiae resulting from either tor2-21, 
lst8-2 and rsp5-9 conditional mutants or over-expression of Sit4p and Sap155p 
(Kabir et al., 2005).       
These examples, along with the data from paper II, demonstrate that CCT 
monomers appear to perform a diverse range of functions independently of the 
oligomer.    
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Results 
 
Paper I 
The extent to which cells rely upon CCT function was investigated in paper I 
using 2 different approaches to reduce functional levels of the chaperonin.   
Firstly, an anti-CCTε antibody (recognising an epitope located in the helical 
protrusion of the apical domain) was microinjected into synchronised cell 
populations, leading to an observed delay in cell cycle progression at G1 to S 
phase transition.  To investigate the effect of the antibody on CCT’s substrate 
folding cycle, α-tubulin, β-actin and a fragment of actin containing subdomains 
3 and 4 were translated in vitro in rabbit reticulocyte lysate (a system rich in 
endogenous CCT).  In the presence of this antibody, rates of substrate 
processing were delayed whilst substrate capture rates were unaffected.    
The second way in which levels of functional CCT were reduced was by siRNA 
targeting of CCTζ-1 mRNA resulting in a reduction of total levels of CCT.  
Targeting cells with siRNA probes against the CCTβ, δ or ζ-1 subunits led to 
growth arrest without cell-cycle checkpoint activation.  CCT protein knockdown 
did not have general affects upon total levels of newly synthesized cytoplasmic 
proteins but dramatically affected levels of native cytoskeletal proteins.  Whilst 
total levels of tubulin were significantly reduced just 1 day post-transfection (by 
up to as much as 70% compared to control cells), total actin levels were 
relatively unaffected even after 3 days.  However, although total actin levels 
were unaffected, inability of actin to bind DNase I showed that CCT depleted 
cells have a high proportion of non-native actin.  Observed cell phenotypes 
showing altered cell shape, irregular cytoplasmic actin organisation (as shown 
by immunofluorescence and phalloidin staining) and altered leading and 
retracting cell edges resulting in abnormal cell motility were all indicative that 
the usually meticulously organised actin cytoskeleton had been disrupted by 
reduced levels of functional CCT.   
Therefore, these data demonstrate the dependence upon CCT for cell cycle 
progression and cytoskeletal organisation.  Cell cycle delay can be induced by 
even a fairly subtle disruption to CCT-substrate folding activity (by antibody 
microinjection) and when levels of the CCT complex are greatly reduced by 
siRNA, cytoskeletal organisation is disrupted and cells undergo growth arrest. 
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An important observation from paper I led to the study in paper II.  Biochemical 
analysis of the assembly state of CCT following siRNA targeting of the CCTζ-1 
subunit revealed that levels of the targeted subunit are, as expected, reduced.  
However, as oligomer assembly cannot occur as one monomeric component is 
missing, cells will have increased levels of the other seven non-targeted subunits 
in their monomeric assembly states. 
 
Paper II 
As observed in paper I, siRNA targeting of CCTζ-1 influences cell shape 
resulting in flatter cells with more F-actin staining at the leading edges 
compared to control cells, so in paper II we investigated the effect on cell shape 
of targeting each CCT subunit individually.  Upon the targeting of CCTα, β, γ, 
δ, ζ-1, η or θ subunits, cells appeared larger and flatter relative to control cells, 
however CCTε knockdown cells adopted a spindle-like formation, becoming 
longer and thinner.  This suggests that the presence of monomeric CCTε (found 
in excess when other CCT subunits are the siRNA target) is responsible for 
flattened cell morphology and that spindle shaped cells are most likely a result 
of a lack of CCTε monomer.  Supporting this reasoning, double knockdown 
experiments with CCTε and either CCTβ or δ resulted in spindle shaped cells.  
Cell shape determination is dependent upon cytoskeletal networks and therefore 
we investigated the influence of disrupted CCT levels upon microfilament and 
microtubule re-polymerisation following drug treatment.  The drugs used were 
nocodazole and latrunculin-A which depolymerise microtubules or 
microfilaments by binding β-tubulin or monomeric actin respectively.  Upon 
removal of nocodazole, microtubule re-growth occurs starting with aster 
formation and then elongation of the microtubules towards the cell periphery.  
Compared to control cells, the rate of re-polymerisation is enhanced and the 
amount of unpolymerised tubulin after 1 hour of re-growth is reduced in the 
presence of excess CCT monomers resulting from CCTε and ζ-1 siRNA 
treatment.  Re-growth of actin microfilaments is also affected following 
reduction in CCT levels, but differently than microtubule re-growth.  The effect 
upon F-actin re-growth depends upon the siRNA targeted subunit and whilst 
CCTζ-1 knockdown cells were able to recover, those depleted of CCTε were 
unable to re-polymerise their actin microfilaments.   
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Localisation of both endogenous and epitope-tagged transfected CCT subunits 
was analysed by immunofluorescence.  Cell staining using antibodies 
recognising endogenous CCT subunits was performed to see if any CCT 
subunits could possibly influence polymerisation by co-localising to cytoskeletal 
filaments.  Interestingly CCTε staining was fibrous in appearance, reminiscent 
of F-actin staining.  Co-staining with phalloidin and vinculin confirmed that 
CCTε co-localises to actin microfilaments whilst CCTδ does not.  Staining using 
different endogenous CCTε antibodies confirmed its co-localisation to F-actin 
and additionally revealed a differently localised sub-population of CCTε at the 
cell periphery.  Different antibodies may preferentially stain CCTε in different 
intra-cellular locations due to varying ease of accessibility to different antibody 
epitopes.   The availability of epitopes may depend upon, for example, CCT 
assembly state, protein conformation or protein-protein interactions.  
Immunofluorescence staining for transiently transfected CCT subunits allowed 
them to be compared using an antibody to an incorporated epitope tag, thereby 
eliminating differences in antibody sensitivities for individual subunits.  Whilst 
no subunits were found to localise to microtubules, co-staining with phalloidin 
revealed that CCTε and to a lesser extent CCTθ were localised to F-actin.  
Performing the same experiment with N-terminally truncated CCT subunits that 
are unable to enter the oligomer and therefore remain entirely monomeric, 
revealed three monomeric subunits, CCTε, ζ and θ, localising to F-actin 
structures.  Biochemical analysis of cell extracts following detergent based 
removal of soluble cytosolic proteins, revealed that the CCT remaining 
associated with the non-extracted fraction (containing intact cytoskeletal 
networks) was found predominantly as monomeric subunits.  This is consistent 
with monomeric CCT subunits being involved in cytoskeletal organisation 
downstream of the folding of newly synthesised actin and tubulin polypeptide 
chains. 
 
Paper III  
In paper III the actin severing / capping protein gelsolin is identified as a novel 
CCT-binding protein via a proteomics approach using immunoprecipitation and 
liquid chromatography – mass spectrometry / mass spectrometry.  Potential 
gelsolin-CCT interactions in vivo were also shown by using proximity ligation 
assays with anti-CCTε and anti-gelsolin primary antibodies. 
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Interactions between the CCT oligomer and its folding substrates actin and 
tubulin are well characterised in a rabbit reticulocyte lysate in vitro translation 
system.  Translation of gelsolin in the same system demonstrated CCT binding 
kinetics distinct from those of actin – an obligate CCT substrate.  As opposed to 
binding to, being folded by and subsequently released from CCT, a small 
percentage of total gelsolin slowly binds and accumulates on the chaperonin 
oligomer.  Structurally, gelsolin is composed of six individual domains, each of 
which were individually translated in rabbit reticulocyte lysate.  Comparing the 
binding of these six domains to CCT, domain 4 shows higher affinity binding 
than the other 5 domains, suggesting that gelsolin may bind CCT with some 
degree of specificity.     
Due to the role of gelsolin in microfilament re-modelling, identifying it as a 
CCT binding protein raises the question as to whether disruption of CCT subunit 
levels affects gelsolin levels as the findings of papers I and II implicate CCT 
subunit activity in cytoskeletal organisation and cell shape determination.  If 
gelsolin were an obligate folding substrate of CCT, reducing levels of CCT 
oligomer by siRNA would have a knock-on effect and functional gelsolin levels 
should be reduced similarly regardless of the targeted CCT subunit.  However, 
the fact that gelsolin levels are affected differently depending upon the CCT 
subunit targeted by siRNA, demonstrates that gelsolin does not behave as an 
obligate substrate.  When CCTγ, δ or θ are targeted, levels of gelsolin are 
elevated relative to the control, whereas targeting CCTβ with siRNA reduces 
gelsolin levels.  Cell staining shows that in both control and siRNA treated cells 
higher gelsolin levels appear to correlate to cells that are narrower as opposed to 
those flatter in appearance.   
The fact that gelsolin is a CCT-binding protein identifies another link between 
CCT and cytoskeletal organisation, further broadening the role of this essential 
chaperonin beyond its protein folding activity essential for newly synthesised 
proteins.      
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Discussion 
 
Levels of functional CCT are important for cell cycle progression and 
cytoskeletal integrity 
In paper I microinjection of an anti-CCT antibody (which delays the rate at 
which the CCT chaperonin is able fold its substrates) induces a delay in cell 
cycle, whilst siRNA targeting of CCT has a more severe effect, resulting in 
complete cell cycle arrest.  These data demonstrate the importance of CCT for 
cell cycle progression.  Consistent with the timing of the observed cell cycle 
delay, under normal conditions levels of CCT subunits (at both the mRNA and 
protein levels) are most up-regulated during G1/S phase transition of the cell 
cycle (Yokota et al., 1999).  The fact that CCT levels fluctuate throughout cell 
growth suggests that the requirement for native CCT substrates varies similarly 
and that chaperonin levels are up-regulated to satisfy such demands.  
Furthermore, tubulin synthesis levels peak around the G1/S transition whereas 
actin levels remain fairly consistent throughout the cell cycle (Yokota et al., 
1999).  This suggests that, in the presence of the CCTε antibody, levels of newly 
folded tubulin monomers may be reduced below a functional threshold, causing 
the observed delay in cell cycle progression.  Cdh1, a protein involved in G1/S 
transition relies upon CCT for folding to its functional conformation (Camasses 
et al., 2003).  However, native levels of this protein were unaffected by the 
presence of CCTε antibody (paper I), indicating that loss of its function was not 
the cause of the observed cell cycle delay.   
Whilst cells injected with the antibody were able to progress through S phase, 
albeit at a delayed rate, when cells were treated with siRNA the effect is more 
severe and cell growth was arrested.  This arrest occurred non-synchronously 
and without checkpoint activation.  This suggests that growth arrest occurs 
whenever levels of CCT substrates required for subsequent cell cycle 
progression are insufficient and cannot be replenished as CCT is depleted.   
No global effects upon the levels of newly synthesised proteins were observed in 
cells with reduced levels of functional CCT, this could be expected due to the 
limited range of CCT obligate substrates, but contrasts the effects observed upon 
GroEL deletion in E. coli (Chapman et al., 2006), whereby 30-40% of 
cytoplasmic proteins become insoluble.  However, CCT siRNA severely 
affected levels of native actin and tubulin.  The observed decreases in total 
31 
   
tubulin levels and native actin levels demonstrate that both tubulin and actin rely 
upon CCT activity for folding to their native state.  Within a time frame where at 
least 30% of CCT remains relative to the control, it appears that total tubulin 
levels have already halved, consistent with reports that tubulin levels are tightly 
regulated.  For example, tubulin mRNA stability and synthesis rates are 
controlled by cytosolic tubulin concentrations and α- and β-tubulin levels are 
regulated relative to one other (Cleveland and Theodorakis, 1994).      
CCT subunit deletion mutants are non-viable (Stoldt et al., 1996), as would be 
expected if functional CCT is essential for cell homeostasis.  Cytoskeletal 
abnormalities in papers I and II support the hypothesis that CCT function is 
necessary for cytoskeletal organisation; actin and tubulins’ dependence upon 
functional CCT levels should result in a disrupted cytoskeleton upon reduced 
CCT function.  This also holds true when considering the effect of CCT 
mutants.  A point mutation anc2-1 in the CCT4 subunit (Vinh and Drubin, 1994) 
results in a disorganised actin cytoskeleton (Vinh and Drubin, 1994).  Although 
mapped to the outside surface of the apical domain (Llorca et al., 1999a), a 
region not involved in CCT-substrate interactions, yeast cells carrying this 
mutation have reduced actin processing rates, due to altered allostery of CCT’s 
ATPase activity (Shimon et al., 2008).  Temperature sensitive tcp1-1-3 mutants 
of CCT1 also result in cytoskeletal disorganisation and growth defects, which, 
can be partially rescued by CCT1p expression (Ursic and Culbertson, 1991; 
Ursic et al., 1994).  Furthermore, plp2 yeast mutants have cytoskeletal and cell 
cycle defects consistent with CCT folding substrates essential for these 
processes (Stirling et al., 2007). 
In paper I although levels of total actin remained the same, the ratio between 
G/F-actin was affected upon siRNA targeting of CCT subunits.  The pool of G-
actin normally localised at the cells’ leading edge is absent when CCT levels are 
reduced, whilst F-actin levels in these regions increase (paper I). This results in 
altered cytoskeletal organisation at the leading and retracting edges of cells, and 
consequently disrupted cell motility.    
These examples demonstrate both the importance and fragility of the CCT 
system, which if even mildly disrupted has such far-reaching implications for 
cytoskeletal processes and ultimately cell viability.   
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CCT’s influence upon the cytoskeleton extends beyond the folding of newly 
synthesised substrate proteins; monomeric subunits influence cell shape and 
cytoskeletal dynamics 
In paper II the influence of CCT on cytoskeletal organisation was investigated 
and these effects were considered from the perspective of CCT monomeric 
subunits.  Whilst different cell lines and tissues have varying CCT expression 
levels, levels of the 8 individual subunits appear to be tightly regulated (Kubota 
et al., 1999; Yokota et al., 1999).  This, combined with the fact that null mutants 
of CCT subunits are lethal, is consistent with one copy of each subunit 
occupying a fixed position within each ring (Liou and Willison, 1997).  When 
siRNA targets one CCT subunit, levels of the targeted subunit will be reduced 
whilst levels of the other subunits as monomers will increase (as oligomers 
cannot be formed) (paper I) and in paper II this was used to study the effects of 
individual CCT monomers.  Previous reports have suggested roles for CCT 
monomers in cytoskeletal organisation, CCTα, γ, ζ and θ subunits have been 
shown to act as microtubule associated proteins (MAPs) (Roobol et al., 1999b) 
and CCTα has been shown to localise to centrosomes (Brown et al., 1996).     
In paper II, CCTε was revealed as a key player in cytoskeletal organisation, 
influencing cell shape and actin polymerisation.  In vitro studies have shown 
previously that CCT can interact with actin during polymerisation (Grantham et 
al., 2002) influencing the rate of polymerisation but not the final yield.  
Following polymerisation, not all subunits were found associated to the same 
degree and CCTδ, a keystone in CCT-actin interactions during folding, was not 
found associated with microfilaments (Grantham et al., 2002) consistent with 
paper II where no co-localisation of CCTδ to microfilaments was seen.  This 
suggests that different CCT subunits are involved in interactions with actin 
monomers during folding and with polymerised F-actin.  Rates of actin re-
polymerisation following drug induced depolymerisation are dependent upon 
which monomeric CCT subunits are present in excess (paper II) and cells 
lacking CCTε cannot re-polymerise their microfilaments, indicative of this 
subunit, when monomeric, influencing F-actin.  CCTε and to a lesser extent ζ 
and θ co-localise to actin stress fibres, only a subset of which are decorated with 
CCT subunits, possibly representing the dynamic and heterogeneous nature of 
F-actin filaments and stress fibres.  The actin turnover dynamics of individual 
stress fibres vary, and the less dynamic they are the more prominent they 
become (Bertling et al., 2004; Hotulainen et al., 2005).  Therefore, as the stress 
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fibres decorated with CCT subunits tend to be those with weaker phalloidin 
staining; this may represent those that are more dynamic with higher rates of 
actin monomer exchange.  As well as varying dynamics, F-actin filaments can 
also have different structural conformations (Egelman and Orlova, 1995a; 
1995b).  The structure they adopt may depend upon proteins bound to the 
filament and likewise F-actin binding proteins may only be able to bind to one 
or other form (Reisler and Egelman, 2007), therefore perhaps the sub-population 
of CCT bound filaments represents F-actin in a certain conformation.   
Together papers I and II demonstrate the importance for CCT for the integrity of 
the cytoskeleton.  Furthermore, CCT subunits in their monomeric form have 
been implicated as potential regulators of cell shape and mammalian 
cytoskeletal dynamics.  These emerging roles for CCT allow a model to develop 
describing its interactions with actin and tubulin from nascent polypeptide 
chains to fully assembled cytoskeletal structures (Figure 4).    
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Figure 4: The interaction between CCT and the cytoskeleton extends beyond the folding of 
newly synthesised polypeptides, and involves interactions with monomeric CCT subunits.  
CCT monomers have been shown to influence microtubule and microfilament polymerisation 
and cell shape.  Levels of CCTε have been implicated as a factor for cell shape determination 
and this subunit has been shown to co-localise to microfilaments.  As shown in the insert, 
when CCTε is targeted by siRNA, levels of monomer decrease and cells adopt a spindle-
shaped morphology, conversely when other CCT subunits are targeted, levels of monomeric 
CCTε will increase and result in flattened cell shapes.      
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Gelsolin binds CCT, but not as an obligate folding substrate 
Gelsolin is a protein involved in regulating and remodelling the actin 
cytoskeleton via its role as an actin severing and capping protein.  Gelsolin 
promotes actin dynamics more effectively than filament-capping actin binding 
proteins, because as a result of its severing action it increases the number of 
actin filaments.  Although filament capping prevents elongation, this is 
reversible and in presence of PIP2, ADF or cofilin, uncapped filament ends will 
experience rapid turnover (e.g. Sun et al., 1999), therefore gelsolin’s influence 
upon cytoskeletal dynamics extends beyond its severing mechanism.   
Gelsolin is the founding member of a family of actin binding proteins containing 
gelsolin-like structural repeats.  Gelsolin has six such domains whose structure 
and interactions with actin filaments have been characterised.  Calcium 
activation is required to induce conformational changes in gelsolin, exposing 
actin binding sites and thereby facilitating gelsolin-actin interactions.  A 
schematic representation of gelsolin structure and the way in which 
conformational changes facilitate F-actin severing and capping are shown in 
figure 5.   
Following the identification of gelsolin as a CCT-interacting protein, the binding 
of gelsolin to CCT was investigated.  Gelsolin appears to bind CCT most 
strongly via domain 4, which may indicate that gelsolin binds to the CCT 
chaperonin with some degree of sequence specificity.  Gelsolin’s six domains   
share a high degree of structural similarly and conserved sequence (Burtnick et 
al., 1997).  However functional interactions such as gelsolin-actin binding are 
mediated via residues which vary between the different domains (Kwiatkowski, 
1999).  This may also hold true for gelsolin-CCT binding, consistent with 
domain 4 containing sequence specific CCT-binding determinants, which may 
not be present in the other domains.         
Despite this specificity of its interaction, gelsolin does not appear to be 
“processed” by CCT in the same way as the CCT substrate actin (paper III).  
Gelsolin slowly accumulates on CCT over time, whereas actin binds to, and is 
subsequently released from the chaperonin (paper III and e.g. Grantham et al., 
2000; McCormack et al., 2001a; McCormack et al., 2001b).  This difference 
suggests that it is unlikely that gelsolin is dependent upon CCT to reach its 
native conformation.  Furthermore, functional gelsolin and individual domains / 
groups of domains are commonly made in the absence of CCT, for example 
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when expressed recombinantly in E. coli (e.g. Azuma et al., 2000; Nag et al., 
2009; Robinson et al., 1999).  Gelsolin is a calcium regulated protein and in the 
presence of calcium undergoes major conformational rearrangements, shifting 
from a closed, inactive form to an extended, active conformation (Figure 5).  
Structural studies on the effects of gelsolin domains’ calcium binding properties 
were performed with recombinantly expressed gelsolin (e.g. Choe et al., 2002; 
Robinson et al., 1999), therefore suggesting that CCT interactions are not 
required for gelsolin’s ability to respond to calcium activation.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: A cartoon representation of gelsolin’s structure (A).  In the inactive form of 
gelsolin, a “latch” helix from the C-terminus of domain 6 blocks actin filament binding sites 
in domain 2, upon calcium activation this latch is released from domain 2 (B).  
Conformational changes occur around the 53 amino acid linker between domains 3 and 4 and 
domain 2 binds F-actin thereby positioning domain 1 correctly for actin interactions.  Domain 
1 disrupts actin-actin interactions causing filament severing and when the C-terminal domains 
4-6 swing across, binding a different actin monomer of the opposite side of the filament, 
capping is complete (C) (Figure based upon Burtnick et al., 1997).       
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In paper III we show that gelsolin levels are affected by CCT subunit levels.  
When CCTβ is depleted by siRNA, total gelsolin levels are reduced, whereas 
CCTγ, δ or θ targeted cells display elevated gelsolin levels.  This is once again 
supportive of the fact that gelsolin is probably not a CCT substrate; if it were, 
gelsolin levels would be expected to decrease when the oligomer levels are 
depleted by siRNA.  Furthermore, the effect of each individual CCT subunit 
would be the same.  The observation that gelsolin levels are affected differently 
depednign upon the CCT subunit targeted by siRNA suggests some level of 
inter-dependence between CCT and gelsolin.   
Levels of gelsolin have been linked with cancer cell motility and tumour 
invasiveness both of which depend upon the actin cytoskeleton.  Gelsolin 
expression levels are reduced in 60-90% of tumours from a wide variety of 
tissues (reviewed by e.g. Kwiatkowski, 1999) and although this role of gelsolin 
as a tumour suppressor is consistent with reduced gelsolin mediated apoptosis, 
gelsolin null mutants do not have increased tumour incidence rates.  
Furthermore, other reports suggest that increased levels of gelsolin increase cell 
motility and invasiveness (Van den Abbeele et al., 2007) and can be linked to 
poor disease prognosis (Shieh et al., 1999), therefore suggestive of gelsolin as a 
tumour activator.  Gelsolin’s role in cancer progression is obviously complicated 
and so far largely undefined.  However, as a mediator of actin cytoskeleton 
remodelling and apoptosis, both of which can influence cancer development, 
gelsolin may hold important clues for cancer research.   
In paper III we have shown that there is a close association between gelsolin, an 
F-actin severing and capping protein and CCT, suggestive of another possible 
way in which CCT contributes to the regulation of cytoskeletal organisation.   
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Concluding Remarks 
 
The work described in this thesis has established new links between the 
mammalian cytoskeleton and the molecular chaperone CCT.   
Functional CCT has been shown to be essential for cell cycle progression and 
cytoskeletal organisation.  CCT monomers have been implicated in influencing 
cell shape and the polymerisation of microfilaments and microtubules.  
Furthermore, the actin regulating protein gelsolin has been identified as a CCT-
binding protein.   
Together these findings suggest that mammalian cytoskeletal organisation is 
governed by mechanisms dependent upon CCT.  Identifying gelsolin as a CCT-
interacting protein may broaden the ways in which CCT can regulate the actin 
cytoskeleton.   
Interactions between CCT and cytoskeletal proteins therefore extend beyond 
CCT’s role in the folding of newly synthesised polypeptides to influencing 
established cytoskeletal networks.  Furthermore, this involves CCT subunits in 
their monomeric assembly state, suggesting a role independent of the CCT 
oligomer.   
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